Conscience and Every Cure launch partnership to advance drug repurposing
We are pleased to announce a new partnership with Every Cure. Every Cure is a U.S.-based nonprofit on a mission to save and improve lives by repurposing drugs; the organization leverages AI to uncover new uses for existing medicines to address diseases with high unmet need. They validate the most promising opportunities through laboratory research […]
Enamine joins the CACHE Governing Board
We are pleased to announce that Enamine has joined the CACHE (Critical Assessment of Computational Hit-finding Experiments) Governing Board. Enamine has already played a central role in CACHE, serving as the primary supplier of compounds for the challenges since the very beginning. Founded in 1991, Enamine is the leading provider of chemical compounds and a […]
Upcoming Request for Proposals: Developing Medicines through Open Science
We are excited to announce Conscience’s upcoming Request for Proposals for the Developing Medicines through Open Science program! This initiative is designed to foster collaborative drug discovery and development in areas often overlooked by the pharmaceutical industry, such as orphan diseases and antimicrobial resistance. The inaugural round of this program will offer a total of […]
John Wilbanks and Owen Roberts Join Conscience Board
The Conscience Board of Directors welcomes its two newest Board appointments: Owen Roberts and John Wilbanks. Owen and John bring a wealth of experience in the development of solutions and innovation in health and drug development. Owen has helped to grow and lead new ventures and established organizations in pharma and biotech. John has over […]
